Condition

Acquired Immune Deficiency Syndrome (AIDS)

ClinicalTrials.gov condition label

Clinical trials10
Recruiting0
Common interventions17
Lead sponsors shown3

Clinical trials

10 shown
Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIVNCT02016924 · 2014-01-16
ACTIVE_NOT_RECRUITING
Enhanced HIV Prevention in Couples: Feasibility Study #3NCT02027519 · 2013-12-01
COMPLETED
Two Part Study to Evaluate Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric ParticipantsNCT01923311 · 2013-08-26
TERMINATED
Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed ChildrenNCT01854775 · 2013-05-06
COMPLETED
Enhanced Prevention in Couples: Feasibility Study #2NCT02027441 · 2012-09-01
COMPLETED
Multi-level Determinants of Starting ART Late: Aim 3NCT01997359 · 2012-06-01
COMPLETED
Pediatric Enhanced Surveillance StudyNCT02043769 · 2012-04-01
COMPLETED
Multi-level Determinants of Starting ART Late: Aim 2NCT01997346 · 2011-11-01
COMPLETED
Enhanced HIV Prevention in Couples: Feasibility Study #1NCT02027714 · 2011-04-01
COMPLETED
Impact of Nutrition Intervention on HIV/AIDS Infected PatientsNCT01171495 · 2008-04-01
COMPLETED

Trial status mix

COMPLETED8
ACTIVE_NOT_RECRUITING1
TERMINATED1

Phase mix

PHASE34
PHASE23

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.